-
Je něco špatně v tomto záznamu ?
Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trial
P. Ostadal, R. Rokyta, J. Karasek, A. Kruger, D. Vondrakova, M. Janotka, J. Naar, J. Smalcova, M. Hubatova, M. Hromadka, S. Volovar, M. Seyfrydova, A. Linhart, J. Belohlavek, ECMO‐CS Investigators
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, randomizované kontrolované studie, multicentrická studie
Grantová podpora
15-27994A
Czech Health Research Council
Charles University in Prague, Cooperatio Cardiovascular Sciences
PubMed
39113628
DOI
10.1002/ejhf.3398
Knihovny.cz E-zdroje
- MeSH
- časové faktory MeSH
- jednotky intenzivní péče MeSH
- kardiogenní šok * terapie mortalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- mimotělní membránová oxygenace * metody MeSH
- míra přežití trendy MeSH
- senioři MeSH
- umělé dýchání metody MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
AIMS: Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30 days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial. METHODS AND RESULTS: The ECMO-CS trial randomized 117 patients with severe or rapidly progressing cardiogenic shock to immediate initiation of ECMO or early conservative strategy. The primary endpoint for this analysis was 1-year all-cause mortality. Secondary endpoints included a composite of death, resuscitated cardiac arrest or implantation of another mechanical circulatory support device, duration of mechanical ventilation, and the length of intensive care unit (ICU) and hospital stays. In addition, an unplanned post-hoc subgroup analysis was performed. At 1 year, all-cause death occurred in 40 of 58 (69.0%) patients in the ECMO arm and in 40 of 59 (67.8%) in the early conservative arm (hazard ratio [HR] 1.02, 95% confidence interval [CI] 0.66-1.58; p = 0.93). The composite endpoint occurred in 43 (74.1%) patients in the ECMO group and in 47 (79.7%) patients in the early conservative group (HR 0.83, 95% CI 0.55-1.25; p = 0.29). The durations of mechanical ventilation, ICU stay and hospital stay were comparable between groups. Significant interaction with treatment strategy and 1-year mortality was observed in subgroups according to baseline mean arterial pressure (MAP) indicating lower mortality in the subgroup with low baseline MAP (<63 mmHg: HR 0.58, 95% CI 0.29-1.16; pinteraction = 0.017). CONCLUSIONS: Among patients with severe or rapidly progressing cardiogenic shock, immediate initiation of ECMO did not improve clinical outcomes at 1 year compared to the early conservative strategy. However, immediate ECMO initiation might be beneficial in patients with advanced haemodynamic compromise.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010523
- 003
- CZ-PrNML
- 005
- 20250429134922.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ejhf.3398 $2 doi
- 035 __
- $a (PubMed)39113628
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Ostadal, Petr $u Department of Cardiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/000000019550222X $7 xx0036674
- 245 10
- $a Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: 1-year outcomes of the multicentre, randomized ECMO-CS trial / $c P. Ostadal, R. Rokyta, J. Karasek, A. Kruger, D. Vondrakova, M. Janotka, J. Naar, J. Smalcova, M. Hubatova, M. Hromadka, S. Volovar, M. Seyfrydova, A. Linhart, J. Belohlavek, ECMO‐CS Investigators
- 520 9_
- $a AIMS: Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30 days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial. METHODS AND RESULTS: The ECMO-CS trial randomized 117 patients with severe or rapidly progressing cardiogenic shock to immediate initiation of ECMO or early conservative strategy. The primary endpoint for this analysis was 1-year all-cause mortality. Secondary endpoints included a composite of death, resuscitated cardiac arrest or implantation of another mechanical circulatory support device, duration of mechanical ventilation, and the length of intensive care unit (ICU) and hospital stays. In addition, an unplanned post-hoc subgroup analysis was performed. At 1 year, all-cause death occurred in 40 of 58 (69.0%) patients in the ECMO arm and in 40 of 59 (67.8%) in the early conservative arm (hazard ratio [HR] 1.02, 95% confidence interval [CI] 0.66-1.58; p = 0.93). The composite endpoint occurred in 43 (74.1%) patients in the ECMO group and in 47 (79.7%) patients in the early conservative group (HR 0.83, 95% CI 0.55-1.25; p = 0.29). The durations of mechanical ventilation, ICU stay and hospital stay were comparable between groups. Significant interaction with treatment strategy and 1-year mortality was observed in subgroups according to baseline mean arterial pressure (MAP) indicating lower mortality in the subgroup with low baseline MAP (<63 mmHg: HR 0.58, 95% CI 0.29-1.16; pinteraction = 0.017). CONCLUSIONS: Among patients with severe or rapidly progressing cardiogenic shock, immediate initiation of ECMO did not improve clinical outcomes at 1 year compared to the early conservative strategy. However, immediate ECMO initiation might be beneficial in patients with advanced haemodynamic compromise.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mimotělní membránová oxygenace $x metody $7 D015199
- 650 12
- $a kardiogenní šok $x terapie $x mortalita $7 D012770
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a umělé dýchání $x metody $7 D012121
- 650 _2
- $a jednotky intenzivní péče $7 D007362
- 650 _2
- $a míra přežití $x trendy $7 D015996
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Rokyta, Richard $u Department of Cardiology, University Hospital and Faculty of Medicine Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Karasek, Jiri $u Hospital Liberec, Liberec, Czech Republic $u Department of Emergency Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Kruger, Andreas $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Vondrakova, Dagmar $u Department of Cardiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Janotka, Marek $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Naar, Jan $u Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Smalcova, Jana $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Hubatova, Marketa $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Hromadka, Milan $u Department of Cardiology, University Hospital and Faculty of Medicine Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Volovar, Stefan $u Department of Cardiology, University Hospital and Faculty of Medicine Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Seyfrydova, Miroslava $u Department of Cardiology, University Hospital and Faculty of Medicine Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Linhart, Ales $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Belohlavek, Jan $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 710 2_
- $a ECMO‐CS Investigators
- 773 0_
- $w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 27, č. 1 (2025), s. 30-36
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39113628 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134917 $b ABA008
- 999 __
- $a ok $b bmc $g 2311722 $s 1247604
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 27 $c 1 $d 30-36 $e 20240808 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
- GRA __
- $a 15-27994A $p Czech Health Research Council
- GRA __
- $p Charles University in Prague, Cooperatio Cardiovascular Sciences
- LZP __
- $a Pubmed-20250415
